Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021
HomeFDAIMPROVACUTER® Gel & Clot Activator Tube and the IMPROSAFE® Blood Collection System Received an Annual FDA Registration Renewal

IMPROVACUTER® Gel & Clot Activator Tube and the IMPROSAFE® Blood Collection System Received an Annual FDA Registration Renewal

GIMDx, Inc., a US subsidiary of Guangzhou Improve Medical Instruments Co., Ltd., announced today that the IMPROVACUTER® Gel & Clot Activator Tube and the IMPROSAFE® Blood Collection System received an annual FDA registration renewal allowing for the continued commercial expansion and distribution of these products in the US healthcare market.

The IMPROVACUTER® Gel & Clot Activator Tube and the IMPROSAFE® Blood Collection System were originally registered with the FDA in 2010.

GIMDx states the IMPROVACUTER® Gel & Clot Activator Tube is a single use tube used to collect, transport, separate, and process venous blood specimens to obtain serum for clinical chemistry and immunology assays. One of its advantages over other brands in the market is having a superior serum separation method. This achieved by balancing the weights of the components to be separated. Additionally, the tube is designed to accommodate for actual local altitudes since the vacuum of these tubes compensates for external pressure. This is particularly important in low temperature environments that are common in the United States.

Furthermore, the IMPROSAFE® Blood Collection System is a venous blood drawing system that is a sterile, innocuous, convenient and safe medical device. Its tri-bevel needles are smooth and gentle, and the venipuncture is much less painful to the patient due a silicone coating around and inside the device.

Improve Medical’s blood collection systems and products are a complete solution for the pre-analytical, analytical and post- analytical phases of testing in clinical laboratories.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

FDA Authorizes Software that Can Help Identify Prostate Cancer

The software is called Paige Prostate and is compatible for use with slide images that have been digitized using a scanner.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy